Doctors express serious doubts about health reforms

October 1, 2010
Sales and Marketing BMA, NHS, healthcare reform, reform

The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …

GPs urge more patient ‘self care’ for minor ailments

September 30, 2010
Medical Communications Doctors.net.uk, OTC, doctors, pharma, simon grime

 Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …

Caelyx rights to revert back to Janssen

September 30, 2010
Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …

Herceptin packs

New Herceptin data sways NICE

September 30, 2010
Sales and Marketing Herceptin, NICE, Roche

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …

Termeer exit could help Sanofi

September 30, 2010
Sales and Marketing Genzyme, M&A, MA, Sanofi

Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …

Nestlé to pioneer ‘health science nutrition’

September 29, 2010
Sales and Marketing Alzheimer's, health science nutrition, nestle

Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …

EuropeanParliamentWEB

Europe votes for patients’ access to information

September 29, 2010
Medical Communications, Sales and Marketing Europe, medicines information

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …

ClinTec recruits former Wyeth VP

September 29, 2010
Research and Development ClinTec, appointment, research and development

Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …

FDA director of manufacturing and product quality Rich Friedman

The FDA Interview: Is pharma getting worse at manufacturing?

September 29, 2010
Manufacturing and Production, Research and Development FDA, manufacturing, manufacturing compliance

It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …

Talking Point: Collaboration required for online activities

September 29, 2010
Medical Communications Red Door, Talking Point, digital

Communicating with customers and patients digitally is top of many people’s agenda at the moment – it’s an exciting area …

Contract research news in brief

September 29, 2010
Research and Development CIT, Cardialysis, PPD, Parexel, Porsolt, Sticares

A round-up of recent news from the CRO sector, featuring updates from CIT, Parexel, PPD, Cardialysis/Sticares and Porsolt. French non-clinical …

Outcomes based measures for Pharma new commercial models

September 29, 2010
Sales and Marketing Kinapse, White paper

It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …

New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale

September 29, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …

Pay people to be healthy, say NICE advisors

September 28, 2010
NHS, NICE, public health

The NHS should use financial incentives to encourage people to make healthier lifestyle changes, according to NICE’s Citizen’s Council. The …

Grünenthal breaches Code with off-label promotion

September 28, 2010
Medical Communications Code of Practice, Grunenthal, PMCPA, Versatis

Grünenthal has been severely criticised in two rulings by UK pharma’s self-regulatory body the PMCPA for promoting off-label use of …

Pfizer slims down pipeline

September 28, 2010
Research and Development Pfizer

Pfizer has reduced the number of drugs in its product pipeline as part of a broad refocusing of its R&D …

EU trailing as China moves ahead with master file plans

September 28, 2010
Manufacturing and Production API, China, EU, excipients

There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …

Helvoet breaks ground on Indian packaging plant

September 28, 2010
Manufacturing and Production Helvoet, packaging

Helvoet Pharma of Belgium has started officially started construction of a new production facility in India that is scheduled to …

European Commission eyes pharma ethics

September 27, 2010
Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics

The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …

Late stage cancer drug failure for AstraZeneca

September 27, 2010
Sales and Marketing AstraZeneca, prostate cancer, zibotentan

AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …

The Gateway to Local Adoption Series

Latest content